Stay updated on PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A sitewide NIH banner announces that federal agencies are transitioning to use “Super Intelligence” instead of “Artificial Intelligence,” with links to updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-24T13:54:02.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now displays software revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T13:58:08.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The website’s footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T13:59:42.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the record history and the previous revision v3.6.6 was removed, updating the version history reflected on the page.
    Difference
    0.1%
    Check dated 2026-09-19T14:31:36.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.6) has been added to the study's history. This updates the record from the previous version (v3.6.5).
    Difference
    0.1%
    Check dated 2026-08-29T14:22:28.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Record History shows Revision: v3.6.5, replacing v3.6.4. This reflects a minor platform release update to the history page rather than any substantive changes to the trial information.
    Difference
    0.1%
    Check dated 2026-08-08T13:06:39.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.